Revvity RVTY
NYSE RVTY
$129.72 +3.37 (+2.67%)
As of: Aug 27, 2026 · 3:59 PM EDT

Revvity (RVTY) Total Non-Current Liabilities (2010 - 2026)

Revvity's (RVTY) quarterly Total Non-Current Liabilities came in at $4.0 billion in Q2 2026, down 14.69% YoY from $4.7 billion in Q2 2025, and down 2.37% on a QoQ basis from $4.1 billion in Q4 2025.

Revvity (RVTY) Total Non-Current Liabilities (2010 - 2026) Analysis & Trends

Revvity (RVTY) has 17 years of Total Non-Current Liabilities data on file, last reported at $4.0 billion in Q2 2026.

  • Quarterly Total Non-Current Liabilities fell 14.69% year-over-year to $4.0 billion in Q2 2026, while the trailing twelve-month figure through Apr 2026 was $4.0 billion (down 14.69% YoY) and the FY2025 annual result came in at $4.1 billion, down 12.61% from the prior year.
  • Total Non-Current Liabilities declined to $4.0 billion in Q2 2026, from $4.1 billion in the prior quarter.
  • In the past five years, Total Non-Current Liabilities ranged from a high of $7.8 billion in Q1 2022 to a low of $4.0 billion in Q3 2024.
  • A 5-year average of $5.5 billion and a median of $5.5 billion in 2022 frame the typical range for Total Non-Current Liabilities.
  • Annual changes were most pronounced in 2022 — Total Non-Current Liabilities soared 84.78% — and 2024, when it fell 16.77%.
  • Tracing RVTY's Total Non-Current Liabilities over 5 years: stood at $5.5 billion in 2022, then grew by 2.26% to $5.7 billion in 2023, then declined by 16.77% to $4.7 billion in 2024, then slipped by 12.61% to $4.1 billion in 2025, then retreated by 2.37% to $4.0 billion in 2026.
  • The last three Total Non-Current Liabilities figures came in at $4.0 billion (Q2 2026), $4.1 billion (Q4 2025), and $4.0 billion (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Thermo Fisher Scientific 234.15 Bn 230.09 Bn 8.34 Bn 108.64 Bn
2 Danaher 152.10 Bn 147.75 Bn 3.61 Bn 85.84 Bn
3 Natera 48.48 Bn 47.38 Bn 486.15 Mn 715.49 Mn
4 Agilent Technologies 44.35 Bn 42.55 Bn 990.00 Mn 5.45 Bn
5 Iqvia Holdings 43.68 Bn 41.60 Bn 1.44 Bn 22.94 Bn
6 Idexx Laboratories 43.02 Bn 42.83 Bn 779.09 Mn 542.10 Mn
7 Illumina 34.39 Bn 33.22 Bn 770.00 Mn 6.36 Bn
8 Mettler Toledo International 28.29 Bn 28.24 Bn 650.22 Mn 3.39 Bn
9 Labcorp Holdings 27.51 Bn 27.37 Bn 1.11 Bn 9.19 Bn
10 Revvity 14.41 Bn 13.39 Bn 416.87 Mn 4.05 Bn

Historic Data

Download Data
DateValue
Jul 5, 2026 4.05 Bn
Apr 5, 2026 4.79 Bn
Dec 28, 2025 4.11 Bn
Sep 28, 2025 4.01 Bn
Jun 29, 2025 4.79 Bn
Mar 30, 2025 4.70 Bn
Dec 29, 2024 4.70 Bn
Sep 29, 2024 4.00 Bn
Jun 30, 2024 5.52 Bn
Mar 31, 2024 5.56 Bn
Dec 31, 2023 5.65 Bn
Oct 1, 2023 4.73 Bn
Jul 2, 2023 6.31 Bn
Apr 2, 2023 6.56 Bn
Jan 1, 2023 6.70 Bn
Oct 2, 2022 5.53 Bn
Jul 3, 2022 6.97 Bn
Apr 3, 2022 7.61 Bn
Jan 2, 2022 7.80 Bn
Oct 3, 2021 6.43 Bn